Zaknoen L. Sara's most recent trade in Atyr Pharma Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Atyr Pharma Inc | Zaknoen L. Sara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |